AzTrials
AzTrials

Preterm InfantNCT03748914

C-UCM and Cerebral Oxygenation and Perfusion

A study testing Intervention Group in people with Preterm Infant and Term Infant, run by Medical University of Graz at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this randomized controlled Pilot study the effects of cut-umbilical cord milking on cerebral oxygenation and perfusion measured via near-infrared spectroscopy (NIRS) and the effects on stroke volume (SV) and cardiac output (CO) also measured non-invasively in term and preterm infants are evaluated for the first 15… Read more about this study

Who is it for?
Ages 1 minute to 15 minutesHealthy volunteers can take part
Conditions the study is for
Preterm Infant, Term Infant, Transition
What is being tested?
Intervention Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteAustria
Study dates
21 Nov 2018to 18 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 minute to 15 minutes
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Neonates with a gestational age ≥28 weeks
  • Delivered by caesarean section
  • Decision to conduct full life support
  • Written informed consent prior to birth

Who cannot join

  • Neonates with a gestational age <28 weeks
  • No decision to conduct full life support
  • No written informed consent
  • Severe congenital malformations

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Dep. of Pediatrics, Medical University of Graz

    Graz, Styria, 8036

Other trials in Austria

About this study

Official title: The Influence of Cut-umbilical Cord Milking (C-UCM) on the Cerebral Oxygenation and Perfusion of Preterm and Term Infants

In this randomized controlled Pilot study the effects of cut-umbilical cord milking on cerebral oxygenation and perfusion measured via near-infrared spectroscopy (NIRS) and the effects on stroke volume (SV) and cardiac output (CO) also measured non-invasively in term and preterm infants are evaluated for the first 15 minutes after birth and compared to a control group.

Read the detailed description

Background

The transition to life after birth is a complex physiological process where the neonate has to establish sufficient ventilation and changes from intra-uterine circulation to extra-uterine circulation take place. During these processes the neonate has to provide the brain with adequate perfusion and oxygen delivery to maintain normal cerebral tissue oxygenation and activity. Instability of cerebral perfusion and oxygenation may be associated with brain damage in preterm infants. The concept of C-UCM may substitute the adverse effects of immediate cord clamping by supplying additional placental blood to the infant, which is mostly performed during caesarean section or in the critically ill neonate.

In this randomized controlled Pilot study the effects of cut-umbilical cord milking on cerebral oxygenation and perfusion measured via near-infrared spectroscopy (NIRS) and the effects on stroke volume (SV) and cardiac output (CO) also measured non-invasively in term and preterm infants are evaluated for the first 15 minutes after birth and compared to a control group.

Aim

The aim of the study is to analyse whether C-UCM in preterm and term infants results in an improvement of cerebral oxygenation and perfusion during immediate neonatal transition measured with NIRS.

Hypotheses

Infants undergoing C-UCM after birth compared to infants without C-UCM show differences in cerebral oxygenation and perfusion in the first 15 min after birth.

Hypothesis I: C-UCM and cerebral blood volume (CBV) In infants with C-UCM there is more CBV decrease immediately after birth, compared to infants without C-UCM, due to improved cerebral oxygen delivery.

Hypothesis II: C-UCM and cerebral regional oxygen saturation (crSO2) Infants with C-UCM have higher crSO2 values during immediate neonatal transition, compared to infants without C-UCM, again due to improved cerebral oxygen delivery.

Hypothesis III: C-UCM and stroke volume (SV) In infants with C-UCM the SV at 15 minutes after birth is higher, compared to infants without C-UCM

Hypothesis IV: C-UCM and cardiac output (CO) In infants with C-UCM the CO at 15 minutes after birth is higher, compared to infants without C-UCM.

Hypothesis V: C-UCM and mean arterial blood pressure (MABP) In infants with C-UCM the MABP at 5, 10 and 15 minutes after birth is higher, compared to infants without C-UCM.

Study population

Preterm infants Neonates with a gestational age ≥28 - 37 weeks delivered by caesarean section at the Department of Obstetrics and Gynaecology, Medical University of Graz, will be enrolled into the study, provided written informed consent is obtained from parents prior to birth. Neonates with severe congenital malformations will be excluded.

Term Infants Neonates with a gestational age ≥37 weeks delivered by caesarean section at the Department of Obstetrics and Gynaecology, Medical University of Graz, will be enrolled into the study, provided written informed consent is obtained from parents prior to birth. Neonates with severe congenital malformations will be excluded.

Study design

The present study is designed as a randomized controlled pilot trial. As there have not been prior human studies investigating C-UCM regarding the outcome measures cerebral oxygenation and perfusion, a randomized controlled pilot study is the appropriate first step to be able to calculate sample size for a bigger trial.

Sample Size

Sample size calculations were not performed, since there are no data from previous human studies available, and this pilot study needs to be conducted to generate data for the sample size calculation of a consecutive main study. For this pilot study a sample size of 80 infants (20 subjects in the intervention group of preterm infants, 20 subjects in the intervention group of term infants, 20 subjects in each of the two control groups) is arbitrary designated.

Procedure

The medical history focussing on any pathologic findings during pregnancy and delivery will be collected and stored anonymously.

After delivery of the neonate via caesarean section, in the intervention group the umbilical cord will be clamped within 30 seconds and cut long at least 30 cm by the obstetrician. The neonate is then placed under an overhead heater by the midwife. There, the umbilical cord must be untwisted and held in a vertical position. It is milked once by the neonatologist towards the baby at a speed of approximately 10 cm/s and then clamped 3 cm from the umbilicus by one member of the clinical team. In contrast, in the control group the umbilical cord is cut according to the standard procedure and no C-UCM is performed. The further treatment procedure is the same in both groups.

A NIRS transducer will be placed on the newborn's left forehead, and fixed with a modified neonatal CPAP cap or gauze bandage by a scientific staff member without disturbing routine medical care. Furthermore, a pulse oximeter sensor will be attached on the right wrist or palm to monitor preductal oxygen saturation by pulse oximetry (SpO2) and heart rate (HR). Moreover 4 electrodes are fixed on the skin for the non-invasive cardiac output monitoring (NICOM) to evaluate SV and CO. All the measurements will be performed within the first 15 minutes after birth.

Intervention The pneumatic cuff for the oscillometric measurements of the arterial blood pressure will be placed around the left upper arm (or alternatively on the left lower leg) at 5, 10 and 15 minutes after birth. A capillary blood gas check 15 minutes after birth will be performed in all the patients; However infants in need for respiratory support during postnatal stabilisation receive this blood gas check routinely. Moreover, rectal temperature will be measured at 15 minutes after birth.

A stopwatch is started at delivery, the time points of umbilical cord clamping, C-UCM in the intervention group, establishment of NIRS measurement, establishment of SpO2 measurement, and blood drawing for the gas check will be noted.

Being tested
Intervention Group, Control Group
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention GroupOther

    Also called Cut umbilical cord milking (C-UCM)

    After delivery of the neonate via caesarean section the umbilical cord will be clamped within 30 seconds and cut long at least 30 cm by the obstetrician. The neonate is then placed under an overhead heater by the midwife. There, the umbilical cord must be untwisted and held in a vertical position. It is milked once by the neonatologist towards the baby at a speed of approximately 10 cm/s and then clamped 3 cm from the umbilicus by one member of the clinical team.

  • Control GroupOther

    Also called Standard care

    The umbilical cord is cut according to the standard procedure and no C-UCM is performed.

Study groups in NCT03748914
Study groupRoleWhat they receive
Intervention GroupExperimentalMilking the cut umbilical cord once towards the Infant at a speed of 10cm/second.
Receives: Other: Intervention Group
Control GroupActive comparatorThe umbilical cord is cut according to the standard procedure and no C-UCM is performed.
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cerebral blood volume

    Changes in CBV (ml/100g brain)

    Measured: within the first 15 minutes after birth.

Secondary outcomes (6)
  1. Cerebral tissue oxygenation index

    Changes in cTOI (%)

    Measured: within the first 15 minutes after birth

  2. Peripheral oxygen saturation

    Changes in SpO2 (%)

    Measured: within the first 15 minutes after birth

  3. Heart rate

    Changes in HR (beats per minute)

    Measured: within the first 15 minutes after birth

  4. Stroke volume

    Changes in SV (ml)

    Measured: within the first 15 minutes after birth

  5. Cardiac output

    Changes in CO (l/min)

    Measured: within the first 15 minutes after birth

  6. Mean arterial blood pressure

    Changes in MABP (mmHg)

    Measured: within the first 15 minutes after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2018
  2. Study start21 Nov 2018
  3. Primary completion18 Nov 2019
  4. Study completion18 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03748914
Sponsor's protocol ID
30-450 ex 17/18
Other IDs
U1111-1223-3280
Status last verified
Mar 2021
First submitted
14 Nov 2018
Last updated
16 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intervention Group in people with Preterm Infant and Term Infant, run by Medical University of Graz at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cerebral blood volume (time frame: within the first 15 minutes after birth.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in